联环药业：预计2025年度归属于上市公司股东的净利润为负值

Core Viewpoint - Lianhuan Pharmaceutical (600513.SH) announced that its financial department has conducted preliminary calculations, predicting a negative net profit attributable to shareholders for the fiscal year 2025, indicating an expected operational loss for that year [1] Financial Performance - The company anticipates a net profit for 2025 to be negative, suggesting a decline in financial performance [1]